B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SYK

MOLECULAR TARGET

spleen associated tyrosine kinase

NCBI Gene: 6850201 compounds

SYK (spleen associated tyrosine kinase) is targeted by 201 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SYK

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dasatinib2.309
2Ouabain1.956
3Crizotinib1.795
4sp6001251.795
5Atorvastatin1.614
6Simvastatin1.614
7Methotrexate1.614
8Chlorhexidine1.614
9Clofarabine1.614
10Colchicine1.614
11cycloheximide1.614
12deguelin [Supplementary Concept]1.614
13Digoxin1.614
14Disulfiram1.614
15Emetine1.614
16Ezetimibe1.614
17Lovastatin1.614
18Medroxyprogesterone Acetate1.614
19Melphalan1.614
20Mometasone Furoate1.614
21Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of1.614
22Niclosamide1.614
23piceatannol1.614
24Podophyllotoxin1.614
25Thapsigargin1.614
26torin 11.614
27trichostatic acid [Supplementary Concept] related to trichostatin1.614
28Trifluridine1.614
29tyrphostin ag 14781.614
30fisetin1.393
31ag4901.393
32alpelisib1.393
33Axitinib1.393
34Azathioprine1.393
35Bortezomib1.393
36Maprotiline1.393
37Nocodazole Nocodazole is1.393
38N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide [Supplementary Concept]1.393
39Tripterygium1.393
40Vincristine1.393
41withaferin1.393
42Berberine1.102
43cbd1.102
44Doxycycline1.102
45Methylene Blue1.102
46Minocycline1.102
47Sertraline1.102
48Spermidine1.102
49Ursolic Acid1.102
502-Methoxyestradiol1.102

Showing top 50 of 201 compounds. Use the BiohacksAI search to explore all SYK modulators.

About SYK as a Drug Target

SYK (spleen associated tyrosine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 201 compounds with documented SYK interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SYK inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.